An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
Clinical trial NCT02326740 · TERMINATED
Trial details
- NCT number
- NCT02326740
- Sponsor
- XOMA (US) LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.